Almac Clinical Technologies Launches IXR Express: A new way for clients to accelerate the clinical trial process

July 31, 2007

23 July 2007 Yardley, PA. Almac, the leading provider of complex randomization, patient tracking and inventory management technologies for clinical trials introduces IXR Express, an IXR (Interactive Voice & Web Response) solution that meets the needs of even the most aggressive study start-up timelines. IXR Express is not a one size fits all application, it is a flexible solution created to meet the functional needs of a larger percentage of clinical trials than the standard configurable offerings currently on the market.

With over 12 years of providing interactive technologies to the clinical trial market, Almac understands that every trial is unique. More than just a simple, pre-configured system, IXR Express has been created to meet the needs of simple to moderately complex trials and provides users the option of managing activities over the phone, the web or both. Further, IXR Express is backed by Almac’s unmatched commitment to quality and customer service.

Jim Murphy, President of Almac Clinical Technologies, comments

“Almac has applied its years of experience as an IVRS and Clinical Technology leader to establish a solution that allows sponsors to accelerate the study start-up process without surrendering their ability to have the right solution to meet the needs of their study.”

About Almac

Almac Clinical Technologies is a division of Almac that specializes in interactive technology and service solutions to increase the quality and efficiency of the clinical trial process. Our solutions include Interactive Voice and Web Response Systems (IXRS™) for patient randomization, tracking and clinical supply management, iTrial EDC for electronic case report form data collection, electronic patient reported outcome data collection, and web drug reconciliation.

Almac and its affiliated companies (Almac Diagnostic Services, Almac Sciences, Almac Clinical Services, Almac Clinical Technologies and Almac Pharma Services) provide a broad range of services across drug discovery, diagnostics, pharmaceutical research and development, manufacture of API, clinical trials and drug product manufacture. US operations are based in Pennsylvania, North Carolina and California. European operations are headquartered in Craigavon, Northern Ireland with additional operations in London and Edinburgh.

Contact: Meghan Adams US: 267-685-4284 / clinicaltechnologies@almacgroup.com

Website: www.almacgroup.com

Share

Back to news